Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for Procedural Pain in Preterm Infants
NCT01477892Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2011
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of remifentanil in procedural pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Premature Infant Pain Profile. Started Dec 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT01477892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01477892.